We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$10.3B
AUM Growth
+$4.59B
Cap. Flow
+$3.41B
Cap. Flow %
32.95%
Top 10 Hldgs %
18.2%
Holding
970
New
347
Increased
294
Reduced
63
Closed
219
Avg Time Held Equity + Options
1.3 quarters
Top 10 Avg Time Held Equity + Options
1 quarter
Top 20 Avg Time Held Equity + Options
1.6 quarters
Avg Time Held Equity only
1.3 quarters
Top 10 Avg Time Held Equity only
1 quarter
Top 20 Avg Time Held Equity only
1.6 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.85%
2 Industrials 15.86%
3 Consumer Discretionary 15.68%
4 Consumer Staples 11.68%
5 Technology 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
QADA
401
DELISTED
QAD Inc.
QADA
$1.67M 0.02%
+68,934
New +$1.47M
2015 Q1
0 quarters
RXII
402
DELISTED
GALENA BIOPHARMA INC COM
RXII
$1.66M 0.02%
+1,193,942
New +$1.66M
2015 Q1
0 quarters
ATRC icon
403
AtriCure
ATRC
$2.91B
$1.64M 0.02%
80,000
+20,000
+33% +$387K
2014 Q1
4 quarters
GCVRZ
404
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$1.64M 0.02%
2,414,838
+1,211,660
+101% +$847K
2013 Q2
7 quarters
OMF icon
405
OneMain Financial
OMF
$6.44B
$1.63M 0.02%
+31,548
New +$1.27M
2015 Q1
0 quarters
FL icon
406
DELISTED
Foot Locker
FL
$1.63M 0.02%
25,914
-468,360
-95% -$26.6M
2013 Q2
7 quarters
BSFT
407
DELISTED
BroadSoft, Inc.
BSFT
$1.63M 0.02%
+48,694
New +$1.46M
2015 Q1
0 quarters
GDX icon
408
VanEck Gold Miners ETF
GDX
$26.6B
$1.6M 0.02%
+87,959
New +$1.8M
2015 Q1
0 quarters
SGMO icon
409
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.57M 0.02%
100,000
+20,000
+25% +$309K
2013 Q3
6 quarters
VMI icon
410
Valmont Industries
VMI
$9.02B
$1.55M 0.02%
+12,640
New +$1.55M
2015 Q1
0 quarters
GEO icon
411
The GEO Group
GEO
$4.18B
$1.53M 0.01%
52,599
+22,992
+78% +$656K
2014 Q3
2 quarters
KPTI icon
412
Karyopharm Therapeutics
KPTI
$11.5M
$1.53M 0.01%
+3,333
New +$1.44M
2015 Q1
0 quarters
CLW icon
413
Clearwater Paper
CLW
$301M
$1.52M 0.01%
23,342
+15,304
+190% +$1.02M
2014 Q4
1 quarter
CNCE
414
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1.51M 0.01%
+100,000
New +$1.4M
2015 Q1
0 quarters
SWN icon
415
DELISTED
Southwestern Energy Company
SWN
$1.5M 0.01%
+64,548
New +$1.6M
2015 Q1
0 quarters
CIVI icon
416
DELISTED
Civitas Solutions, Inc.
CIVI
$1.48M 0.01%
70,722
-19,278
-21% -$370K
2014 Q4
1 quarter
BNCL
417
DELISTED
Beneficial Bancorp, Inc.
BNCL
$1.47M 0.01%
+130,230
New +$1.44M
2015 Q1
0 quarters
AMH icon
418
American Homes 4 Rent
AMH
$11B
$1.47M 0.01%
+88,600
New +$1.48M
2015 Q1
0 quarters
CCG icon
419
DELISTED
CAMPUS CREST COMMUNITIES INC COM STK (MD)
CCG
$1.45M 0.01%
+202,284
New +$1.5M
2015 Q1
0 quarters
ALDR
420
DELISTED
Alder Biopharmaceuticals
ALDR
$1.44M 0.01%
+50,000
New +$1.37M
2015 Q1
0 quarters
GAS
421
DELISTED
AGL Resources Inc
GAS
$1.44M 0.01%
29,034
+16,402
+130% +$851K
2014 Q2
3 quarters
HIFR
422
DELISTED
InfraREIT, Inc.
HIFR
$1.43M 0.01%
+50,000
New +$1.35M
2015 Q1
0 quarters
OTIC
423
DELISTED
Otonomy, Inc.
OTIC
$1.41M 0.01%
+40,000
New +$1.37M
2015 Q1
0 quarters
AGNC icon
424
AGNC Investment
AGNC
$10.3B
$1.39M 0.01%
64,968
+39,812
+158% +$861K
2014 Q4
1 quarter
CLLS icon
425
Cellectis
CLLS
$119M
$1.38M 0.01%
+40,000
New +$1.45M
2015 Q1
0 quarters

Similar funds

UBS O'Connor's Q1 2015 Portfolio in Review

As of Q1 2015, UBS O'Connor held 970 positions worth $10.3B, up 80% from $5.75B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor deployed $3.41B of net new capital in Q1 2015, opening 347 new positions and adding to 294 existing holdings. Its largest new stake was SALIX PHARMACEUTICALS LTD DEL: 1,567,292 shares worth $271M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Humana, an estimated $57.6M trimmed.

  • UBS O'Connor's largest Q1 2015 buy was SALIX PHARMACEUTICALS LTD DEL: 1,567,292 shares worth $271M.
  • UBS O'Connor added most to Nielsen Holdings plc in Q1 2015, an estimated $110M increase.
  • UBS O'Connor's biggest Q1 2015 reduction was Humana, cutting an estimated $57.6M.
  • UBS O'Connor fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $142M.
  • UBS O'Connor's ten largest holdings make up 18% of its $10.3B portfolio in Q1 2015.
  • UBS O'Connor opened 347 new positions and closed 219 in Q1 2015.
  • UBS O'Connor's portfolio value rose 80% quarter-over-quarter to $10.3B.

Based on UBS O'Connor's 13F filing for Q1 2015, filed 14 May 2015.